StockNews.com assumed coverage on shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the stock. A number of other equities research analysts have also issued reports on the company. Jefferies Financial Group lowered Reata Pharmaceuticals from a buy rating to […]
Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Free Report)’s share price reached a new 52-week high on Tuesday . The stock traded as high as $172.15 and last traded at $172.11, with a volume of 341874 shares traded. The stock had previously closed at $172.05. Wall Street Analysts Forecast Growth Several equities research analysts have recently […]
Short Interest in Reata Pharmaceuticals, Inc. (NASDAQ:RETA) Decreases By 38.1% kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Reata Pharmaceuticals (NASDAQ:RETA) Receives Neutral Rating from Cantor Fitzgerald themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Integral Health Asset Management LLC lowered its position in shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Free Report) by 16.5% in the first quarter, HoldingsChannel reports. The firm owned 71,000 shares of the company’s stock after selling 14,000 shares during the period. Integral Health Asset Management LLC’s holdings in Reata Pharmaceuticals were worth $6,455,000 at […]